Dermatology
Private equity in dermatology: Consolidation, modernization are on the horizon
Over the past decade, dermatology practices have become attractive investment opportunities for private equity firms.
VIDEO: Long-term data for lebrikizumab show possible management of itch
In this video, Raj Chovatiya, MD, PhD, discussed results of a study following patients with atopic dermatitis who were on lebrikizumab for 3 continuous years.
VIDEO: ROCKET-Horizon Trial achieves primary, secondary endpoints
In this video, Raj Chovatiya, MD, PhD, discussed continued research on rocatinlumab in the ROCKET HORIZON Trial.
‘Medicine is in crisis’: Future of dermatology relies on telehealth
It has been 5 years since the start of the COVID-19 pandemic, which forced many providers to embrace telehealth.
Desai: Path to successful leadership paved with servitude, introspection, authenticity
ORLANDO — Seemal R. Desai, MD, FAAD, who is finishing his term as American Academy of Dermatology president, took time to reflect on his own leadership journey and inspire future leaders at the Skin of Color Society Scientific Symposium.
Treatment Guidelines for DM
Differential Diagnosis
Clinical Presentation
Key Features of Dermatomyositis
VIDEO: JAK inhibitors in dermatology effective, ‘safer than we could have ever hoped for’
MIAMI BEACH, Fla. — Janus kinase inhibitors are an incredibly important, new tool that have exemplified both high efficacy and safety, according to a speaker at South Beach Symposium.